Fatty acid turnover in the ischaemic compared to the non-ischaemic human heart
✍ Scribed by Lennart Kaijser; Martin Ericsson; Göran Walldius
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 291 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0300-8177
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The effects of chronic oral fenoldopam in the treatment of NYHA grade II-III heart failure secondary to ischaemic heart disease, were studied in a placebo controlled, double blind, randomised, parallel group fashion in 20 patients. Nine patients taking placebo and six taking fenoldopam completed the
Heart fatty acid binding protein (hFABP) is an abundant 14-kDa cytosolic protein thought to be involved in trafficking of fatty acids from the plasma membrane to sites of r-oxidation in mitochondria and peroxisomes and to the endoplasmic reticulum for lipid synthesis. A human hFABP cDNA isolated by